Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-17-056202

SVP, Regulatory Affairs & Qual sold 11,500 shares at $50.00 ($575,000)

  • SVP, Regulatory Affairs & Qual acquired 11,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ruff Shamim · SVP, Regulatory Affairs & Qual

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-10-03 Exercise or conversion : show line 1 in the form +11,500 $14.76 $169,740 38,545 D
2017-10-03 Sale : show line 2 in the form −11,500 $50.00 $575,000 27,045 D
Open-market sales · 11,500 sh · avg $50.00 · $575,000

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2017-10-03 Exercise or conversion : show line 3 in the form Non-Qualified Stock Options (right to buy) −11,500 $14.76 $169,740 $14.76 2025-05-06 11,500 41,144 D
Loading xslF345X03/doc4.xml…